DOUBLE-BLIND STUDY, RANDOMISED, ACTIVE AND PLACEBO CONTROLLED TO ASSESS THE CLINICAL EFFICACY, SKIN TOLERABILITY AND PHARMACOLOGICAL ACTIVITY OF UR-1505 OINTMENT AT THREE DIFFERENT STRENGHTS IN PATIENTS WITH MILD TO MODERATE PLAQUE-TYPE PSORIASIS.
Latest Information Update: 09 Jul 2012
At a glance
- Drugs UR 1505 (Primary) ; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Palau Pharma
Most Recent Events
- 09 Aug 2011 New trial record